OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
TA338747-100 Antibody 50 ug Rabbit Polyclonal Anti-KCNH2 Antibody $325 3-7 days
SC124103 Human cDNA pCMV6-XL4 KCNH2 (untagged)-Human potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3 NM_172057.1 $1480 Immediate
RC216897 Human ORF PS100001 KCNH2 (Myc-DDK-tagged)-Human potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3 $1180 Immediate
RC216897L1 Human ORF PS100064 Lenti-ORF clone of KCNH2 (Myc-DDK-tagged)-Human potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3, (10ug) $1550 3-4 weeks
RC216897L2 Human ORF PS100071 Lenti-ORF clone of KCNH2 (mGFP-tagged)-Human potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3, (10ug) $1710 3-4 weeks
RG216897 Human ORF PS100010 KCNH2 (GFP-tagged) - Human potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3 $1300 6-7 weeks
LC406815 Lysate KCNH2 HEK293T cell transient overexpression lysate (as WB positive control) $50 In Stock
LY406815 Lysate Transient overexpression lysate of potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2), transcript variant 3 $480 5 days
/ UTR pMirTarget 3`UTR clone of potassium voltage-gated channel subfamily H (eag-related) member 2 (KCNH2) transcript variant 3 for miRNA target validation NM_172057.1 $495 3-4 weeks
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title